Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study.

Authors: Dimitrakopoulos, Foteinos-Ioannis, Mountzios, Giannis, Christopoulos, Petros, Papastergiou, Thomas, Elshiaty, Mariam, Daniello, Lea, Zervas, Elefterios, Agelaki, Sofia, Samantas, Epaminondas, Nikolaidi, Adamantia, Athanasiadis, Ilias, Baka, Sofia, Syrigos, Konstantinos, Christopoulou, Athina, Lianos, Evangelos, Samitas, Konstantinos, Tsoukalas, Nikolaos, Perdikouri, Eleni-Isidora, Oikonomopoulos, George, Kottorou, Anastasia

Source: Therapeutic Advances in Medical Oncology; 9/8/2022, p1-16, 16p